RAPP Scorecard | Rapport Therapeutics, Inc.

Rapport Therapeutics, Inc. (RAPP) Scorecard

2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

4/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q21/3	WinRAPP / S&P 33.17% / 15.20%	LoseRAPP / S&P RAPP unavailable / 15.00%	LoseRAPP / S&P 47.80% / 50.40%
2026-Q11/3	WinRAPP / S&P 3.13% / -4.33%	LoseRAPP / S&P RAPP unavailable / 11.30%	LoseRAPP / S&P -13.67% / 27.70%
2025-Q40/3	LoseRAPP / S&P 2.15% / 2.65%	LoseRAPP / S&P RAPP unavailable / 9.00%	LoseRAPP / S&P -78.72% / 13.40%
2025-Q31/3	WinRAPP / S&P 161.21% / 8.12%	LoseRAPP / S&P RAPP unavailable / 4.61%	LoseRAPP / S&P -89.56% / 13.45%
2025-Q21/3	WinRAPP / S&P 13.36% / 10.94%	LoseRAPP / S&P RAPP unavailable / 4.83%	LoseRAPP / S&P -92.36% / 10.63%
2025-Q10/3	LoseRAPP / S&P -43.46% / -4.27%	LoseRAPP / S&P RAPP unavailable / 4.98%	LoseRAPP / S&P -89.86% / 10.57%
2024-Q40/3	LoseRAPP / S&P -13.38% / 2.41%	LoseRAPP / S&P RAPP unavailable / 5.25%	LoseRAPP / S&P RAPP unavailable / 6.15%
2024-Q30/3	LoseRAPP / S&P -11.95% / 5.89%	LoseRAPP / S&P RAPP unavailable / 5.89%	LoseRAPP / S&P RAPP unavailable / 6.11%
2024-Q20/3	LoseRAPP / S&P RAPP unavailable / 4.28%	LoseRAPP / S&P RAPP unavailable / 5.38%	LoseRAPP / S&P RAPP unavailable / 5.12%
2024-Q10/3	LoseRAPP / S&P RAPP unavailable / 10.56%	LoseRAPP / S&P RAPP unavailable / 5.71%	LoseRAPP / S&P RAPP unavailable / 5.59%
2023-Q40/3	LoseRAPP / S&P RAPP unavailable / 11.69%	LoseRAPP / S&P RAPP unavailable / 6.81%	LoseRAPP / S&P RAPP unavailable / 7.78%
2023-Q30/3	LoseRAPP / S&P RAPP unavailable / -3.27%	LoseRAPP / S&P RAPP unavailable / 7.52%	LoseRAPP / S&P RAPP unavailable / -5.03%
2023-Q20/3	LoseRAPP / S&P RAPP unavailable / 8.74%	LoseRAPP / S&P RAPP unavailable / 9.50%	LoseRAPP / S&P RAPP unavailable / -8.57%
2023-Q10/3	LoseRAPP / S&P RAPP unavailable / 7.50%	LoseRAPP / S&P RAPP unavailable / 10.77%	LoseRAPP / S&P RAPP unavailable / -15.69%
2022-Q40/3	LoseRAPP / S&P RAPP unavailable / 7.56%	LoseRAPP / S&P RAPP unavailable / 11.88%	LoseRAPP / S&P RAPP unavailable / -17.99%
2022-Q30/3	LoseRAPP / S&P RAPP unavailable / -4.88%	LoseRAPP / S&P RAPP unavailable / 13.47%	LoseRAPP / S&P RAPP unavailable / -1.41%
2022-Q20/3	LoseRAPP / S&P RAPP unavailable / -16.10%	LoseRAPP / S&P RAPP unavailable / 13.71%	LoseRAPP / S&P RAPP unavailable / 11.04%
2022-Q10/3	LoseRAPP / S&P RAPP unavailable / -4.60%	LoseRAPP / S&P RAPP unavailable / 15.97%	LoseRAPP / S&P RAPP unavailable / 42.23%
2021-Q40/3	LoseRAPP / S&P RAPP unavailable / 11.03%	LoseRAPP / S&P RAPP unavailable / 15.00%	LoseRAPP / S&P RAPP unavailable / 96.40%
2021-Q30/3	LoseRAPP / S&P RAPP unavailable / 0.58%	LoseRAPP / S&P RAPP unavailable / 10.77%	LoseRAPP / S&P RAPP unavailable / 69.42%
2021-Q20/3	LoseRAPP / S&P RAPP unavailable / 8.55%	LoseRAPP / S&P RAPP unavailable / 6.58%	LoseRAPP / S&P RAPP unavailable / 51.81%
2021-Q10/3	LoseRAPP / S&P RAPP unavailable / 6.17%	LoseRAPP / S&P RAPP unavailable / -1.06%	LoseRAPP / S&P RAPP unavailable / 7.39%
2020-Q40/3	LoseRAPP / S&P RAPP unavailable / 12.15%	LoseRAPP / S&P RAPP unavailable / -3.72%	LoseRAPP / S&P RAPP unavailable / -33.42%
2020-Q30/3	LoseRAPP / S&P RAPP unavailable / 8.93%	LoseRAPP / S&P RAPP unavailable / -2.04%	LoseRAPP / S&P RAPP unavailable / -27.10%
2020-Q20/3	LoseRAPP / S&P RAPP unavailable / 20.54%	LoseRAPP / S&P RAPP unavailable / -0.46%	LoseRAPP / S&P RAPP unavailable / -27.11%
2020-Q10/3	LoseRAPP / S&P RAPP unavailable / -19.60%	LoseRAPP / S&P RAPP unavailable / 3.47%	LoseRAPP / S&P RAPP unavailable / -14.75%
2019-Q40/3	LoseRAPP / S&P RAPP unavailable / 9.07%	LoseRAPP / S&P RAPP unavailable / 5.36%	LoseRAPP / S&P RAPP unavailable / 2.99%
2019-Q30/3	LoseRAPP / S&P RAPP unavailable / 1.70%	LoseRAPP / S&P RAPP unavailable / 5.02%	LoseRAPP / S&P RAPP unavailable / 0.21%
2019-Q20/3	LoseRAPP / S&P RAPP unavailable / 4.30%	LoseRAPP / S&P RAPP unavailable / 6.64%	LoseRAPP / S&P RAPP unavailable / 8.65%
2019-Q10/3	LoseRAPP / S&P RAPP unavailable / 13.65%	LoseRAPP / S&P RAPP unavailable / 8.12%	LoseRAPP / S&P RAPP unavailable / 14.29%
2018-Q40/3	LoseRAPP / S&P RAPP unavailable / -13.52%	LoseRAPP / S&P RAPP unavailable / 9.05%	LoseRAPP / S&P RAPP unavailable / 18.23%
2018-Q30/3	LoseRAPP / S&P RAPP unavailable / 7.71%	LoseRAPP / S&P RAPP unavailable / 10.21%	LoseRAPP / S&P RAPP unavailable / 19.06%
2018-Q20/3	LoseRAPP / S&P RAPP unavailable / 3.43%	LoseRAPP / S&P RAPP unavailable / 9.03%	LoseRAPP / S&P RAPP unavailable / 14.46%
2018-Q10/3	LoseRAPP / S&P RAPP unavailable / -0.76%	LoseRAPP / S&P RAPP unavailable / 7.68%	LoseRAPP / S&P RAPP unavailable / 12.46%
2017-Q40/3	LoseRAPP / S&P RAPP unavailable / 6.64%	LoseRAPP / S&P RAPP unavailable / 7.03%	LoseRAPP / S&P RAPP unavailable / 13.82%
2017-Q30/3	LoseRAPP / S&P RAPP unavailable / 4.48%	LoseRAPP / S&P RAPP unavailable / 5.68%	LoseRAPP / S&P RAPP unavailable / 17.57%
2017-Q20/3	LoseRAPP / S&P RAPP unavailable / 3.09%	LoseRAPP / S&P RAPP unavailable / 4.83%	LoseRAPP / S&P RAPP unavailable / 17.74%
2017-Q10/3	LoseRAPP / S&P RAPP unavailable / 6.07%	LoseRAPP / S&P RAPP unavailable / 3.67%	LoseRAPP / S&P RAPP unavailable / 13.32%
2016-Q40/3	LoseRAPP / S&P RAPP unavailable / 3.82%	LoseRAPP / S&P RAPP unavailable / 2.09%	LoseRAPP / S&P RAPP unavailable / 7.05%
2016-Q30/3	LoseRAPP / S&P RAPP unavailable / 3.85%	LoseRAPP / S&P RAPP unavailable / 0.20%	LoseRAPP / S&P RAPP unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	RAPP total return	S&P 500 Total Return Index
Total return	188.32%	20.78%
Annualized return	188.32%	20.78%

5Y · 2024-06-07 to 2026-08-27

Metric	RAPP total return	S&P 500 Total Return Index
Total return	144.38%	83.14%
Annualized return	19.57%	12.86%

10Y · 2024-06-07 to 2026-08-27

Metric	RAPP total return	S&P 500 Total Return Index
Total return	144.38%	319.30%
Annualized return	9.35%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Stoke Therapeutics, Inc. (STOK)	United States	$1.630B	-9.82
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82
Kailera Therapeutics, Inc. (KLRA)	United States	$1.552B
ANAPTYSBIO, INC (ANAB)	United States	$1.546B	-60.20
Eton Pharmaceuticals, Inc. (ETON)	United States	$1.701B	80.74
Innoviva, Inc. (INVA)	United States	$1.493B	4.62
ArriVent BioPharma, Inc. (AVBP)	United States	$1.485B	-10.25
Xencor Inc (XNCR)	United States	$1.776B	-7.33
Septerna, Inc. (SEPN)	United States	$1.783B	-63.01